An observational cross-sectional survey of rosacea: Clinical associations and progression between subtypes

British Journal of Dermatology

Volumn 169, Issue 3, 2013, Pages 555-562

  Tan, J ^a,b   Blume Peytavi, U ^c   Ortonne, J P ^d   Wilhelm, K ^e   Marticou, L ^f,g   Baltas, E ^h   Rivier, M ⁱ   Petit, L ⁱ   Martel, P ⁱ  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Windsor Clinical Research Inc   (Canada)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^e proDERM Institute for Applied Dermatological Research   (Germany)

^f UNIVERSITY OF LÜBECK   (Germany)

^g Luc Marticou Consulting Loiret   (France)

^h UNIVERSITY OF SZEGED   (Hungary)

ⁱ Galderma R and D   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BURN; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DERMATOLOGIST; DISEASE CLASSIFICATION; DISEASE COURSE; EDEMA; ERYTHEMATOTELANGIECTATIC ROSACEA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OCULAR ROSACEA; PAPULOPUSTULAR ROSACEA; PHYMATOUS ROSACEA; PRIORITY JOURNAL; PRURITUS; ROSACEA; SKIN TENSION;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; ROSACEA; YOUNG ADULT;

EID: 84883343898     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12385     Document Type: Article

References (29)

1. Powell FC,. Clinical practice. Rosacea. N Engl J Med 2005; 352: 793-803.
2. Marks R,. The enigma of rosacea. J Dermatolog Treat 2007; 18: 326-8.
3. Steinhoff M, Buddenkotte J, Aubert J, et al,. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc 2011; 15: 2-11.
4. Schwab VD, Sulk M, Seeliger S, et al,. Neurovascular and neuroimmune aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc 2011; 15: 53-62.
5. Bamford JT, Gessert CE, Renier CM,. Measurement of the severity of rosacea. J Am Acad Dermatol 2004; 51: 697-703.
6. Wilkin J, Dahl M, Detmar M, et al,. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 2002; 46: 584-7.
7. Crawford GH, Pelle MT, James WD,. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004; 51: 327-41; quiz 42-4.
8. Wilkin J, Dahl M, Detmar M, et al,. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 2004; 50: 907-12.
9. van ZE, Graber MA, Hollis S, et al,. Interventions for rosacea. Cochrane Database Syst Rev 2005; 3: CD003262.
10. Spoendlin J, Voegel JJ, Jick SS, et al,. A study on the epidemiology of rosacea in the U.K. Br J Dermatol 2012; 167: 598-605.
11. Wilkin JK,. Rosacea. Int J Dermatol 1983; 22: 393-400.
12. Abram K, Silm H, Maaroos HI, et al,. Risk factors associated with rosacea. J Eur Acad Dermatol Venereol 2010; 24: 565-71.
13. Abram K, Silm H, Oona M,. Prevalence of rosacea in an Estonian working population using a standard classification. Acta Derm Venereol 2010; 90: 269-73.
14. Aksoy B, Altaykan-Hapa A, Egemen D, et al,. The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities. Br J Dermatol 2010; 163: 719-25.
15. Bae YI, Yun SJ, Lee JB, et al,. Clinical evaluation of 168 Korean patients with rosacea: the sun exposure correlates with the erythematotelangiectatic subtype. Ann Dermatol 2009; 21: 243-9.
16. Khaled A, Hammami H, Zeglaoui F, et al,. Rosacea: 244 Tunisian cases. Tunis Med 2010; 88: 597-601.
17. Lazaridou E, Apalla Z, Sotiraki S, et al,. Clinical and laboratory study of rosacea in northern Greece. J Eur Acad Dermatol Venereol 2010; 24: 410-14.
18. Berg M, Liden S,. An epidemiological study of rosacea. Acta Derm Venereol 1989; 69: 419-23.
19. Meyer M, Muller AK, Yang J, et al,. The role of chronic inflammation in cutaneous fibrosis: fibroblast growth factor receptor deficiency in keratinocytes as an example. J Investig Dermatol Symp Proc 2011; 15: 48-52.
20. Kyriakis KP, Palamaras I, Terzoudi S, et al,. Epidemiologic aspects of rosacea. J Am Acad Dermatol 2005; 53: 918-19.
21. Sibenge S, Gawkrodger DJ,. Rosacea: a study of clinical patterns, blood flow, and the role of Demodex folliculorum. J Am Acad Dermatol 1992; 26: 590-3.
22. Lee SY, Choi J-H, Sung K-J, et al,. A clinical study of 112 patients with rosacea. Korean J Dermatol 2001; 39: 636-42.
23. Ghanem VC, Mehra N, Wong S, et al,. The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics. Cornea 2003; 22: 230-3.
24. Quarterman MJ, Johnson DW, Abele DC, et al,. Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline. Arch Dermatol 1997; 133: 49-54.
25. Plewig G, Kligman AM,. Acne and Rosacea, 3rd edn. Berlin: Springer, 2000.
26. Wilkin JK,. Rosacea. Pathophysiology and treatment. Arch Dermatol 1994; 130: 359-62.
27. Rebora A,. Rosacea. J Invest Dermatol 1987; 88: 56s-60s.
28. Scheinfeld N, Berk T,. A review of the diagnosis and treatment of rosacea. Postgrad Med 2010; 122: 139-43.
29. Kligman AM,. A personal critique on the state of knowledge of rosacea. Dermatology 2004; 208: 191-7.